Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of Dideoxycytidine ( ddC ) Versus Zidovudine ( AZT ) in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Therapy.

NCT00000678 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

320

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Zidovudine
DRUG: Zalcitabine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]